Table 1.
Demographic and clinical details of the sample
| Characteristic | People with MND (n=25) | Caregivers (n=10) |
| Age (range 39–80) | ||
| 35–50 years | 3 | 0 |
| 51–65 years | 12 | 4 |
| 66–80 years | 10 | 6 |
| Gender | ||
| Male | 15 | 5 |
| Female | 10 | 5 |
| Relationship to person with MND | ||
| Spouse/partner | 10 | |
| Diagnosis | ||
| ALS limb | 18 | |
| ALS bulbar | 1 | |
| Primary lateral sclerosis | 4 | |
| Progressive bulbar palsy | 1 | |
| Progressive muscular atrophy | 1 | |
| Time since diagnosis (range 2 months to 17 years) | ||
| Less than 1 year | 8 | |
| 1–3 years | 6 | |
| 3–5 years | 7 | |
| More than 5 years | 4 | |
| Difficulties reported often/always* (ALSAQ-5 scale) | ||
| Difficult to stand up | 16 | |
| Difficult to use arms and hands | 16 | |
| Difficulty eating solid food | 4 | |
| Speech is not easy to understand | 9 | |
| Feeling hopeless about the future | 3 | |
| Self-reported concerns about cognitive ability | 2 | |
*ALSAQ-5 is a patient self-report questionnaire used to briefly measure the impact of ALS/MND on patients.51
ALS, Amyotrophic Lateral Sclerosis; ALSAQ-5, Amyotrophic Lateral Sclerosis Assessment Questionnaire 5; MND, motor neuron disease.